Dr. Eleni Katsantoni, from BRFAA’s Division of Hematology-Oncology, is participating in the THALAMOSS network - a Research Program with a total budget of 5M Euro that is funded from the 7th Framework Programme of Research & Development of the European Union.  The Program brings together 13 leading European and US Research Institutions, as well as European and Israeli SMEs with the aim of developing universal sets of markers and techniques for stratification of β-thalassaemia patients into treatment subgroups.  Τhe Program combines patient recruitment/characterization, genomics, proteomics, transcriptomics and gene therapy approaches.